Steroids After Laser Trabeculoplasty for Glaucoma

Completed · Phase 4

Conditions studied: Glaucoma

In brief

The purpose of this study is to determine whether the choice of post-operative eye drop administered after selective laser trabeculoplasty (SLT) for glaucoma affects the efficacy in lowering intraocular pressure (IOP).

Key facts

Study ID

NCT00981435

Run by

Stanford University

People needed

97

Starts

2009-09-01

Expected to finish

2015-09-01

Last updated by the study team

2019-08-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• clinical diagnosis of glaucoma
• clinician has determined that SLT laser is indicated
• IOP currently >18 and was ever >21 in the past (e.g. prior to treatment)

You may not qualify if…

• prior history of uveitis
• prior glaucoma surgery including glaucoma laser surgery
• pregnant or 3 months post-partum

Where it is running

• Bascom Palmer Eye Institute — Miami, Florida, United States
• University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.